Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder

Lisdexamfetamine dimesylate (LDX) is the first prodrug stimulant used for the treatment of attention-deficit/hyperactivity disorder (ADHD) dosed once daily. Due to its long-acting properties, LDX remains pharmacologically inactive until an enzymatic process predominantly associated with red blood ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Najib, Jadwiga, Wimer, Dexter, Zeng, Julie, Lam, Kristina W, Romanyak, Natalya, Paige Morgan, Eva, Thadavila, Anu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571766/
https://www.ncbi.nlm.nih.gov/pubmed/28855799
http://dx.doi.org/10.1177/1179573517728090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571766/
https://www.ncbi.nlm.nih.gov/pubmed/28855799
http://dx.doi.org/10.1177/1179573517728090

Ejemplares similares